Bvf Inc Xenon Pharmaceuticals Inc. Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$28.7 - $46.46 $26.9 Million - $43.6 Million
-937,886 Reduced 51.31%
890,072 $41 Million
Q1 2023

May 15, 2023
BUY
$33.46 - $40.35 $18.6 Million - $22.5 Million
556,715 Added 43.79%
1,827,958 $65.4 Million
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $12.2 Million - $14.6 Million
370,148 Added 41.08%
1,271,243 $50.1 Million
Q3 2022

Nov 14, 2022
SELL
$30.79 - $39.82 $21.5 Million - $27.7 Million
-696,871 Reduced 43.61%
901,095 $32.5 Million
Q1 2022

May 16, 2022
SELL
$25.09 - $33.13 $42.4 Million - $56 Million
-1,691,574 Reduced 51.42%
1,597,966 $48.9 Million
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $26.8 Million - $60.8 Million
1,717,762 Added 109.29%
3,289,540 $103 Million
Q2 2021

Aug 16, 2021
SELL
$16.81 - $20.0 $32.1 Million - $38.2 Million
-1,910,000 Reduced 54.86%
1,571,778 $29.3 Million
Q1 2021

May 17, 2021
SELL
$13.65 - $21.31 $239,803 - $374,374
-17,568 Reduced 0.5%
3,481,778 $62.3 Million
Q3 2020

Nov 13, 2020
SELL
$10.82 - $13.35 $189,404 - $233,691
-17,505 Reduced 0.5%
3,499,346 $38.7 Million
Q2 2020

Aug 14, 2020
BUY
$10.21 - $14.9 $8.6 Million - $12.6 Million
842,513 Added 31.5%
3,516,851 $44.1 Million
Q1 2020

May 15, 2020
BUY
$8.08 - $17.57 $5.86 Million - $12.7 Million
725,263 Added 37.21%
2,674,338 $30.3 Million
Q4 2019

Feb 14, 2020
BUY
$8.11 - $14.65 $1.68 Million - $3.04 Million
207,475 Added 11.91%
1,949,075 $25.6 Million
Q2 2019

Aug 14, 2019
SELL
$8.51 - $10.75 $401,450 - $507,120
-47,174 Reduced 2.64%
1,741,600 $17.2 Million
Q4 2018

Feb 14, 2019
BUY
$5.61 - $12.62 $3.5 Million - $7.87 Million
623,221 Added 53.47%
1,788,774 $11.3 Million
Q3 2018

Nov 14, 2018
BUY
$9.0 - $14.9 $4 Million - $6.63 Million
444,723 Added 61.7%
1,165,553 $15.4 Million
Q1 2018

May 07, 2018
SELL
$2.7 - $4.9 $7.74 Million - $14.1 Million
-2,868,000 Reduced 79.91%
720,830 $3.53 Million
Q3 2017

Nov 14, 2017
BUY
$2.45 - $3.25 $8.79 Million - $11.7 Million
3,588,830
3,588,830 $10.6 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email